Pharma Exclusives Pressreleases
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
Tuesday, April 08, 2025AbbVietoday announced that the European Commission EC granted marketing authorization to RINVOQ upadacitinib mg once daily for the treatment of giant cell arteritis GCA in adult patients RINVOQ is the first and only oral JAK inhibitor approved in th...
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
Monday, April 07, 2025Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltdannounced today that the US Food and Drug Administration FDA has accepted its supplemental Biologics License Application sBLA for AJOVY fremanezumabvfrm to expand
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
Tuesday, April 01, 2025Moderna Inctoday announced that the Australian Therapeutic Goods Administration TGA has granted approval for mRESVIA mRNA an mRNA respiratory syncytial virus RSV vaccine to prevent lower respiratory tract disease
Thermo Fisher Scientific Launches First More Sustainable Large-Capacity and Superspeed Centrifuges with Next-Generation Natural Refrigerant Cooling System
Tuesday, April 01, 2025Thermo Fisher Scientific Inc the world leader in serving science introduced today new lines of floormodel centrifuges to provide more sustainable solutions without compromising performance and sample security The Thermo Scientific Cryofuge Thermo Sci...
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Tuesday, April 01, 2025Pfizer Incannounced today that the European Commission EC has issued a decision amending the marketing authorization for ABRYSVO the companys bivalent respiratory syncytial virus RSV prefusion F RSVpreF vaccine
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
Tuesday, April 01, 2025Eton Pharmaceuticals Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced the outlicensing of commercial rights to Increlex in territories outside of the US to Esteve Pharmace...
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
Tuesday, April 01, 2025Tonix Pharmaceuticals Holding Corp a biopharmaceutical company with a portfolio of marketed products and a pipeline of development candidates today announced the launch of TONIX ONE a fullyintegrated digital platform designed to help patients better...
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
Friday, March 28, 2025Lexicon Pharmaceuticals Inctoday announced that it has entered into an exclusive license agreement with Novo Nordisk AS for LX a firstinclass oral nonincretin development candidate in obesity and associated metabolic disorders
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
Friday, March 28, 2025Bristol Myers Squibb today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has recommended approval of a new Opdivo nivolumab formulation associated with a new route of administration
Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells
Thursday, March 27, 2025Thermo Fisher Scientific Inc the world leader in serving science has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging CZ Imaging Institute
